GlassScriptPhysician profile
Jeffrey L Groffsky
NPI 1861492902
$2,296.46
in general payments reported to CMS, 2019-2025
7 companies · $63.45 in 2025
The $63.45 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,087 · 2020: $356 · 2021: $247 · 2022: $191 · 2023: $352 · 2025: $63.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,518.97 | 2019-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Excluder Aaa Endoprosthesis, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Penumbra, INC. | $587.13 | 2019-2023 | Indigo System |
| Inari Medical, INC. | $109.14 | 2022 | |
| Stryker Corporation | $29.94 | 2025 | Flowtriever, Artix Mt |
| Imperative Care, INC | $18.27 | 2022 | |
| Cardinal Health 200 LLC | $16.99 | 2019 | |
| Becton, Dickinson and Company | $16.02 | 2025 | Vaccess |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Groffsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.